His lab is engaged on refining the alanine-scanning assay to some essential residues that will correctly distinguish among fibrils from neurodegenerative tauopathies. He envisions using this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.Several colleagues have designed the counterargumen